ERBB2 and colorectal carcinoma: Its upregulation was associated to relevant genetic aberrations such as: ERBB2, ERBB3 and FGFR4 overexpression, a finding confirmed in a large series of 60 CRC cell lines (Fig. 3b and Additional file 3: Figure S6A-C).